XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Note 1 - Description of Business
12 Months Ended
Dec. 31, 2021
Notes to Financial Statements  
Business Description and Basis of Presentation [Text Block]

1.

DESCRIPTION OF BUSINESS

 

The Company develops, commercializes and markets a range of automated technologies for chimeric antigen receptor therapies (“CAR-T”) and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The Company was founded in 1986 and is incorporated in the State of Delaware and headquartered in Rancho Cordova, CA.

 

The Company was founded in 1986 and is a Delaware corporation, with headquarters in Rancho Cordova, CA.  Our business involves the manufacturing and related service of cell based medical devices, including the AutoXpress® and BioArchive® platforms for automated clinical bio-banking, PXP® platform for point-of-care cell-based therapies and CAR-TXpress™ platform for large scale cell manufacturing services.  All product lines are reporting as a single reporting segment in the financial statements.

 

Our common stock is traded on the Nasdaq Capital Market exchange under the ticker symbol “THMO”.